Authors


Michael Gamlen

Latest:

Quality Management Systems for Small Biopharmaceutical Organizations

What small biotechs need to know about quality management systems.


Colleen K. Dixon

Latest:

Strategies for Optimizing the CMO-Client Relationship

Partner with a contract manufacturing organization that integrates best practices from project management, customer service, and Lean.


Rae Fischer

Latest:

Myriad Decision Places Biotech at a Crossroads

In light of the new ruling, patent licensees may want to re-evaluate the strength of their licensed patents.



James P. Catania

Latest:

Quality by Design: The Case for Change (Part II)

A rigorous cost-benefit assessment can help to chart a cost-effective path forward.


Teng Liu

Latest:

Development of a Novel Rolling-Tube Cell Culture Platform and Demonstration of System Feasibility

Rolling-tube system balances scale-up accuracy and thoroughput.


Rakesh Kumar, PhD

Latest:

Tangential Flow Filtration for the Recovery of Acellular Pertussis Vaccine Components

Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.



Michele Antonelli, Ph.D.

Latest:

Outsourcing A Survival Strategy or a Tool for Speed to Market A Case Study

Outsourcing is becoming increasingly widespread and essential in the biopharmaceutical industry. Its imprint on biotech world business and on the development of biopharmaceutical drugs is becoming ever more pronounced. It is estimated that almost one-half of biopharmaceutical companies contract out at least part of the production of their products. On the other hand, those companies that do not outsource production often contract out some of their development activities.



Merrill Matthews, Ph.D.

Latest:

Final Word: Riding on the Coattails of US Patients

In general, people in other countries pay less for brand-name prescription drugs than people in the US. As a result, some Americans travel to Canada or Mexico to get their prescriptions, and an increasing number are using the Internet to buy drugs from other countries.


Bing Zhang

Latest:

Analytical Tools for Process and Product Characterization

Select the best approach to determine critical quality attributes.


Derrick Schertz

Latest:

Mathematical Programming for the Design and Analysis of a Biologics Facility-Part 2

An algorithmic approach to fine tune facility design and predict capacity.


Donna Cassidy-Hanley

Latest:

An Alternative Platform for Rapid Production of Effective Subunit Vaccines

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).


M.S. Mahadevan

Latest:

Tangential Flow Filtration for the Recovery of Acellular Pertussis Vaccine Components

Membrane-based TFF technology can ease scale-up and provide a higher recovery percentage compared to conventional purification methods.


Suzannah K. Sundby, Esq.

Latest:

Technology Licensing — From First Steps to Executing a Plan

Carefully prosecuted patent applications lead to patents with valid and enforceable claims that provide broad coverage for your technology.


Joseph F. Pekny

Latest:

Using Simulation to Address Capacity Limitations

Modeling tools help process engineers optimize a biopharmaceutical facility’s capacity.


Tod Marvell

Latest:

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.


Bob Rhoades

Latest:

Supplier Quality Management: A Risk-Based Approach

A systematic classification system makes supplier quality management feasible, even if you are dealing with hundreds of suppliers worldwide.


Maria Lusk

Latest:

Build Versus Buy in the Current Biotech Market Environment

How current economic conditions affect your build-or-buy decision.


Jennifer Mercer

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Ellen Leinfuss

Latest:

Ensuring Product Quality and Managing Risk: Validate, Verify, Implement

Biopharmaceutical companies must follow an active approach to managing their supply chains.



Tim Schofield

Latest:

Quality by Design for Biotechnology Products—Part 3

Regulatory flexibility can make continuous improvement possible.


Arnold McAuley

Latest:

Best Practices for Formulation and Manufacturing of Biotech Drug Products

How to maintain product stability and prevent particulates.


Geoffrey Hodge

Latest:

Media Development for Mammalian Cell Culture

Once a necessary "magic ingredient" of media for mammalian cell culture, serum is rapidly being eliminated from media for biotherapeutic processes.


Yves Aubin

Latest:

Using NMR Spectroscopy to Obtain the Higher Order Structure of Biopharmaceutical Products

Simple methods can characterize polysaccharide vaccines and recombinant cytokines at high resolution.


Alissa Fernald

Latest:

Scale-Up and Comparison Studies Evaluating Disposable Bioreactors and Probes

Process performance was comparable across all scales, and fiber optic sensors appeared interchangeable with conventional probes.


John Ruesch

Latest:

Use of Contract Analytical Laboratories: A Pfizer Global Biologics Perspective

By following key strategies, companies can reduce the risk and increase the benefits of outsourcing analytical development and testing


Ashot Papoyan

Latest:

An Alternative Platform for Rapid Production of Effective Subunit Vaccines

Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).

© 2025 MJH Life Sciences

All rights reserved.